Department of Planning and BudgetAn official website of the Commonwealth of Virginia Here's how you knowAn official websiteHere's how you know
| Action Summary | House bill 2557 placed the drug gabapentin as a controlled substance in Schedule V. Regulations of the Board of Optometry currently prohibit optometrists from prescribing Schedule V drugs. Since July 1, 2019, optometrists have not been able to prescribe gabapentin; therefore, the only alternative they now have for pain control for certain patients is prescribing of an opioid. To remediate the problem, the Board is amending 18VAC105-20-47 to add gabapentin to the TPA formulary. There is also a correction to that section to reflect that there is an exception allowed in A 1 for prescribing hydrocodone in combination with acetaminophen. Subsections A and B are currently inconsistent. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: 2.2-4002(14) |
| RIS Project | Yes [006134] |
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Name / Title: | Kelli Moss / Executive Director |
| Address: |
9960 Mayland Drive Suite 300 Henrico, VA 23233 |
| Email Address: | kelli.moss@dhp.virginia.gov |
| Phone: | (804)597-4077 FAX: (804)793-9145 TDD: ()- |